Vir Biotechnology Inc. (VIR)
NASDAQ: VIR
· Real-Time Price · USD
4.51
0.07 (1.58%)
At close: Aug 15, 2025, 3:59 PM
4.49
-0.43%
After-hours: Aug 15, 2025, 07:24 PM EDT
Vir Biotechnology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.21M | 1.79M | 11.28M | 2.38M | 3.08M | 56.38M | 16.79M | -4.1M | -12.72M | 46.71M | 21.79M | 371.43M | -42.69M | 1.23B | 809.76M | 102.71M | 173.99M | 605K |
Cost of Revenue | 11K | n/a | 684K | 50K | 4.31M | 4.58M | 5.28M | 38K | 22K | 1.91M | 6M | 22.25M | 27.92M | 90.15M | 56.88M | 7.84M | 1.14M | 134.87M |
Gross Profit | 1.2M | 1.79M | 10.59M | 2.33M | -1.24M | 51.8M | 11.51M | -4.14M | -12.74M | 44.8M | 15.79M | 349.18M | -70.61M | 1.14B | 752.88M | 94.88M | 172.84M | -134.26M |
Operating Income | -118.42M | -139.55M | -117.15M | -218.59M | -129.37M | -52.48M | -117.12M | -186.73M | -215.19M | -143.37M | -150.5M | 194.96M | -225.22M | 1.01B | 571.75M | -53.38M | 61.02M | -158.63M |
Interest Income | 10.79M | 12.29M | 14.15M | 17.53M | 18.85M | 21.28M | 20.74M | 21.93M | 23.02M | 21.31M | 16.17M | 9.33M | 2.2M | 388K | 167K | 11K | 97K | 164K |
Pretax Income | -110.79M | -120.95M | -104.67M | -213.54M | -139.89M | -65M | -120.76M | -166.63M | -197.62M | -143.19M | -151.64M | 217.73M | -233.72M | 921.91M | 545.89M | 110.76M | 61.87M | -168.72M |
Net Income | -110.96M | -120.97M | -104.59M | -213.72M | -138.38M | -65.28M | -115.97M | -163.41M | -194.78M | -140.96M | -101.6M | 175.31M | -76.49M | 518.62M | 525.25M | 110.43M | 61.81M | -168.91M |
Selling & General & Admin | 22.28M | 23.94M | 26.7M | 25.74M | 30.27M | 36.27M | 39.09M | 41.08M | 47.1M | 46.78M | 38.74M | 43.17M | 41.59M | 38.26M | 55.78M | 50.5M | 28.78M | 25.74M |
Research & Development | 97.51M | 118.64M | 106.08M | 195.18M | 97.86M | 68.01M | 89.54M | 148.25M | 171.86M | 157.64M | 155.17M | 114.17M | 115.08M | 90.23M | 128.34M | 98.67M | 86.13M | 134.87M |
Other Expenses | n/a | -1.25M | -5.04M | 10.62M | -535K | -287K | n/a | 882K | -367K | -16.25M | -27.62M | -3.13M | 691K | -2.52M | -7K | 64K | 752K | -10.25M |
Operating Expenses | 119.79M | 141.34M | 127.74M | 233.63M | 128.13M | 104.28M | 128.63M | 182.6M | 202.44M | 188.18M | 166.29M | 154.22M | 154.61M | 125.96M | 181.13M | 148.26M | 111.83M | 159.24M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 30.04M | n/a | n/a | n/a |
Cost & Expenses | 119.8M | 141.34M | 128.43M | 231.59M | 132.44M | 108.86M | 133.9M | 182.63M | 202.46M | 190.08M | 172.29M | 176.47M | 182.53M | 216.11M | 238M | 156.1M | 112.97M | 159.24M |
Income Tax Expense | -170K | 16K | -86K | 177K | -1.51M | 276K | -4.78M | -3.21M | -2.85M | -2.23M | -50.03M | 42.42M | -157.23M | 403.29M | 20.64M | 334K | 53K | 196K |
Shares Outstanding (Basic) | 138.45M | 137.47M | 136.81M | 136.65M | 136.23M | 135.28M | 134.61M | 134.29M | 134.06M | 133.55M | 133.15M | 132.73M | 132.45M | 132.08M | 130.97M | 130.67M | 130.12M | 127.74M |
Shares Outstanding (Diluted) | 138.45M | 137.47M | 136.81M | 136.65M | 136.23M | 135.28M | 134.61M | 134.29M | 134.06M | 133.55M | 133.15M | 134.96M | 132.45M | 134.54M | 133.88M | 133.85M | 133.79M | 127.74M |
EPS (Basic) | -0.8 | -0.88 | -0.76 | -1.56 | -1.02 | -0.48 | -0.86 | -1.22 | -1.45 | -1.06 | -0.76 | 1.32 | -0.58 | 3.93 | 4.01 | 0.85 | 0.48 | -1.32 |
EPS (Diluted) | -0.8 | -0.88 | -0.76 | -1.56 | -1.02 | -0.48 | -0.86 | -1.22 | -1.45 | -1.06 | -0.76 | 1.30 | -0.58 | 3.85 | 3.92 | 0.82 | 0.46 | -1.32 |
EBITDA | -118.42M | -136.69M | -114.06M | -215.7M | -128.09M | -75.56M | -134.54M | -182.15M | -205.07M | -137.73M | -148.55M | 194.96M | -223.63M | 1.01B | 549.11M | -51.9M | 61.02M | -157.36M |
EBIT | -118.59M | -139.56M | -121.09M | -218.59M | -132.35M | -65M | -139.02M | -186.73M | -209.82M | -143.37M | -150.5M | 217.73M | -225.22M | 921.91M | 545.89M | -53.38M | 61.87M | -158.63M |
Depreciation & Amortization | n/a | 2.87M | 2.89M | 2.9M | 4.26M | 4.52M | 4.48M | 6.4M | 6.98M | 7.81M | 4.19M | 3.87M | 3.77M | 3.66M | 3.22M | 2.98M | 2.92M | 2.89M |